Ovid Therapeutics Inc. (OVID)
NASDAQ·Healthcare·Biotechnology
$2.51
+7.51%
Mkt Cap $414.34M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (7 analysts)
$5.50
Range $4.00 – $7.00
Implied Upside
+119.6%
Consensus $5.50 vs current $2.51
NASDAQ·Healthcare·Biotechnology
$2.51
+7.51%
Mkt Cap $414.34M
Buy
5
Hold
0
Sell
0
Price Target (7 analysts)
$5.50
Range $4.00 – $7.00
+119.6%
Consensus $5.50 vs current $2.51